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Abstract
Background: While polycystic ovary syndrome (PCOS) is often associated with
psychological distress, its most frequent clinical characteristics include acne, hirsutism
and increased level of androgen hormones.
Objective: To evaluate the level of depression and anxiety, hirsutism, acne, and level
of androgen hormones in PCOS and control group and its association with cognitive
function.
Materials and Methods: This cross-sectional study was conducted on 53 women
with PCOS and 50 healthy women as a control group. Data were collected using
a questionnaire including the samples’ demographic information, clinical features,
clinical findings of hyperandrogenism, and the Beck Depression and Anxiety
questionnaire. In addition, the acne and hirsutism levels of the subjects were evaluated
using the global acne grading system and the Ferriman-Gallwey scoring system,
respectively. The Montreal Cognitive Assessment (MoCA) is a screening test for
cognitive impairment that covers major cognitive domains.
Results: A significant difference was found between the two groups in the mean levels
of acne, hirsutism, total testosterone, free androgen index, depression, and anxiety.
However, some mean values of the MoCA were lower in the women of case group
compared to the control group. Additionally, a significant difference was observed
between the two groups in the domains of visual-spatial ability (p = 0.009), executive
function (p = 0.05), attention (p = 0.03), and total MoCA scores (p = 0.002).
Conclusion: The PCOS women demonstrated significantly lower performance on the
tests of executive function, attention, and visual-spatial function than the healthy control
women.
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1. Introduction
Polycystic ovary syndrome (PCOS) can be
diagnosed in a woman by the presence of at
least two of the following three symptoms: 1)
clinical and/or biochemical hyperandrogenism, 2)
oligomenorrhea/amenorrhea, and 3) polycystic
sonographic view in ovaries (1). It is the most
common hormonal disorder in women of
childbearing age, the prevalence of which is about
16.6% according to the Rotterdam criteria (2, 3).
The symptoms of PCOS include oligomenorrhea,
amenorrhea, obesity, hirsutism, infertility, acne, and
anovulation, which can lead to anxiety, depression,
sexual dysfunction, and social maladjustment (4)
as well as a reduced quality of life, as indicated by
several reports (5, 6). A besides, a large body of
research now suggests that acne (7, 8), hirsutism,
and androgen hormone levels (1, 9, 10) as well
as depression and anxiety (11) can change the
cognitive function.
The purpose of the current study was to evaluate
the level of depression and anxiety, hirsutism,
acne, and level of androgen hormones in PCOS
group and its association with cognitive function
compared to the control group.
2. Materials and Methods
2.1. Participants
This cross-sectional study was conducted on
women with PCOS, who attended the Gynecology
Clinic in Arash Hospital in Tehran, Iran, from
November 2015 to February 2016 in Tehran, Iran.
Fifty-three women with a confirmed diagnosis of
PCOS. Through the Rotterdam criteria (12), and 50
healthy women with normal bleeding were include
and compared. The control group was matched
in terms of age, education level, employment
status, parity, marital status, height, and weight.
After explaining the study objectives, a written
approved informed consent was obtained from all
participants. The inclusion criteria of the studywere
as follows: 1) age: 18-40 yr, 2) lack of recognized
mental illness based on medical records and self-
reports of the participants, 3) minimum literacy
level of primary, 4) not using anti-androgen drugs,
oral contraceptives, or any hormone therapy to
treat the symptoms of PCOS within one month
prior to recruitment, 5) the absence of stressful
events in the last three months, 6) no chronic
illnesses such as diabetes, cancer, cardiovascular
diseases, hypertension, and psychiatric diseases,
7) no smoking, and 8) no history of head injury.
2.2. Measures
2.2.1. Socio-demographic status
Demographic data including the health-related
variables, history of fertility, and information about
socio-demographic characteristics (age, marital
status, occupation, educational status, etc.) were
completed for all participants.
2.2.2. Psychological distress
The Beck Depression Inventory–Second Edition
(BDI-II) is a 21-item self-report measure designed
to measure severity of depression consistent with
symptoms of depression (13). Moreover, the Persian
version of BDI has been reported to be clinically
appropriate for the assessment and research in
the Iranian population by a validation study in Iran
(14).
2.2.3. Cognitive performance
The Montreal Cognitive Assessment (MoCA)
was developed by Ziad Nasreddine in Montreal
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(15). The MoCA assesses six cognitive domains
including (1) executive functions (5 points); (2)
visuospatial abilities (5 points); (3) delayed recall
(short-term memory) (5 points); (4) language (3
points); (5) attention (6 points), concentration, and
working memory (2 points); and (6) temporal and
spatial orientation (6 points) (15). The psychometric
properties of the questionnaire have been verified
among the Iranian population (16).
2.2.4. Hirsutism
Ferriman and Gallwey Scoring System (F/G
score) is amethod of evaluating degree of hirsutism
in females. In each of these areas, a score of 0
(absence of terminal hairs) through 4 (extensive
terminal hair growth) was assigned. A score of eight
or more was considered as positive for hirsutism
according to the FG scoring system (17).
2.2.5. Acne
An assessment of acne was made using the
Global Acne Grading System (GAGS). This system
divides the face, chest and back into six areas
(nose, forehead, chin, each cheek, chest and upper
back). The six locations are graded separately on a
0–4 scores depending on the most severe lesion
within that location (18).
2.2.6. Laboratory measures
We collected venous blood samples in third day
of the follicular phase of the menstrual cycle after
8-hour fast early on the morning of the day. The
total testosterone (TT) and sex hormone-binding
globulin (SHBG) levels were measured by ECLIA
(Cobas.e411. Roche, Germany). The free androgen
index (FAI) can be used to estimate physiologically
active testosterone in humans (19). This index is
calculated as the ratio of TT divided by SHBG level
(both expressed in the same units) and multiplied
by 100 to yield numerical.
2.3. Ethical consideration
This study was approved by the ethics
committee of TarbiatModaresUniversity ofMedical
Sciences (IR.TMU.REC.1394.154). After explaining
the study’s purposes, written consent and verbal
assent were collected from all participants
who were informed that their participation was
voluntary, confidential, and anonymous.
2.4. Statistical analysis
The data were analyzed using the SPSS software
(Statistical Package for the Social Sciences, SPSS
Inc., Chicago, IL, USA), version 22.0. While the
group comparisons were carried out using
the Student’s t test, Mann-Whitney U-test, and
Chi-square test, the relationship between the
variables, we determined using the Pearson’s and
Spearman’s correlation Statistical coefficients. The
statistical significance was set at P < 0.05.
3. Results
Table I describes the demographic
characteristics of study participants and there
were no significant difference between age, Body
Mass Index (BMI), educational status, age, parity,
occupation, and marital status (P > 0.05) (Table I).
The mean scores of clinical parameters such as
hirsutisms and acnewere evaluated in both groups.
TT was significantly higher in the PCOS group. FAI
showed a relatively significant difference between
the two groups. Nevertheless, there was no
significant difference in SHBG between the two
groups. Moreover, we found a significant difference
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in depression and anxiety between the two groups
(Table II).
The evaluation of the two groups with regard
to MoCA showed that some mean values were
statistically and significantly lower in the women in
the case group. Besides, the differences of scores
in the two groups were statistically significant in the
domains of visual-spatial ability, executive function,
attention, and total MoCA scores (Table III).
Table IV shows the association between acne,
hirsutism, androgen hormone levels, and SHBG,
depression and anxiety together with a total
score of cognition and its domains. The results
revealed that executive function was negatively
associated with depression (p = 0.04). However,
no correlations were detected between the MoCA
components and TT, FAI, SHBG, acne, hirsutism,
and anxiety in the case group (Table IV).
Table I. Comparison of demographics characteristics between the two groups
Variables Case (n = 53) Control (n = 50) P-value
Women age (yr)* 28.47 ± 6.27 29.94 ± 6.24 0.23
Parity* 0.84 ± 1 1.20 ± 1.18 0.13
BMI (kg/m2)* 28.74 ± 5.33 27.78 ± 4.45 0.32
Education (yr)* 11.49 ± 3.53 11.88 ± 3.69 0.58
Occupation**
Employed 37 (69) 40 (80)
Housewife 9 (17) 5 (10)
Student 7 (13.2) 5 (10)
0.47
Marital status**
Unmarried 7 (13.2) 7 (14)
Married 43 (81.1) 41 (82)
Divorced 3 (5.7) 2 (4)
0.92
* Data presented as Mean ± SD. Independent Student’s t test; ** Data presented as n (%). Chi square, BMI: Body mass index
Table II. The mean scores of acne, hirsutism, total testosterone, FAI, SHBG, depression and anxiety between the two groups
Variables Case Control P-value
Acne score 11.60 ± 6.89 8.64 ± 6.20 0.02
Hirsutism score 7.56 ± 6.52 2.63 ± 1.68 0.0001
FAI 1.26 ± 0.99 0.82 ± 0.69 0.009
Total testosterone (nmol/L) 0.41 ± 0.18 0.32 ± 0.16 0.008
SHBG 45.94 ± 29.64 51.68 ± 26.33 0.30
Anxiety 17.35 ± 10.44 12.20 ± 9.65 0.01
Depression 20.39 ± 9.85 14.46 ± 8.40 0.001
Data presented as Mean ± SD. t test, FAI: Free androgen index; SHBG: Sex hormone-binding globulin
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Table III. Scores and total scores for the domain subgroups of MoCA between the two groups
Variables Case Control P-value
Total score 22.83 ± 3.4 24.72 ± 2.52 0.002*
Memory 2.98 ± 1.49 3.2 ± 1.29 0.43*
Visual-spatial ability 3.30 ± 0.66 3.62 ± 0.60 0.009**
Executive function 2.71 ± 1.19 3.18 ± 1.02 0.05**
Verbal performance 3.20 ± 0.98 3.34 ± 0.96 0.64**
Attention 4.32 ± 1.54 4.98 ± 0.97 0.03**
Orientation 5.64 ± 0.52 5.64 ± 0.59 0.78**
Data presented as Mean ± SD. *Independent Student’s t test; **Mann-Whitney U-test, MoCA: Montreal cognitive assessment
Table IV. Correlation between acne, hirsutism, androgen hormone levels and SHBG, depression and anxiety with scores and total
scores for the domain subgroups of MoCA
Variables Total score Memory Orientation Attention Verbal
performance
Visual-spatial
ability
Executive
function
Acne
r -0.02** 0.01** -0.025** -0.066** -0.16** 0.003** -0.14**
p 0.85 0.94 0.85 0.64 0.24 0.98 0.30
Hirsutism
r -0.012** -0.08** -0.01** -0.07** 0.01** -0.01** 0.13**
p 0.93 0.55 0.94 0.62 0.89 0.89 0.34
Total testosterone
r -0.14* 0.005* -0.04** -0.20** -0.16** -0.26** 0.071**
p 0.30 0.97 0.77 0.13 0.24 0.06 0.61
SHBG
r -0.01* 0.02* 0.02** -0.034** 0.018** -0.13** -0.03**
p 0.94 0.84 0.88 0.81 0.89 0.35 0.82
FAI
r -0.03* 0.000* -0.03** -0.078** -0.05** -0.05** 0.10**
p 0.78 0.99 0.82 0.57 0.67 0.67 0.44
Depression
r -0.03** -0.061** -0.02** 0.001** -0.03** -0.20** -0.28**
p 0.81 0.66 0.85 0.99 0.79 0.14 0.04
Anxiety
r -0.15** -0.23** 0.13** 0.05** -0.079** 0.085** -0.16**
p 0.26 0.09 0.34 0.72 0.57 0.54 0.23
*Pearson correlation; **Spearman correlation, MoCA: Montreal cognitive assessment; SHBG: Sex hormone-binding globulin;
FAI: Free androgen index; r: Correlation statistical coefficients, p-value consider significant when it < 0.05
https://doi.org/10.18502/ijrm.v18i12.8026 Page 1053
International Journal of Reproductive BioMedicine Mehrabadi et al.
4. Discussion
4.1. Acne and cognitive function
In the present study, there was a significant
difference between the two groups in the mean
levels of acne, hirsutism, total testosterone, free
androgen index, depression, and anxiety. Some
mean values of theMoCAwere in the control group
is higher than the case group. Additionally, the
mean domains of visual-spatial ability, executive
function, attention, and total MoCA scores between
the two groups was significant difference.
Acne is a common skin condition in PCOS,
which has a prevalence of 83% (7). The negative
influence of acne on patients’ psychological
status that may impair cognitive function (20).
We found some studies on cognitive function
in patients with acne vulgaris. Recent studies
showed improvements in cognitive abilities such
as executive function, memory, attention, and
hippocampal-based learning during isotretinoin
therapy (21, 22). The hippocampus plays an
important role in spatial and episodical memories
associated with retinoid acid functions such
as neural plasticity, neurogenesis, induction of
expression receptor neurotrophin, promoting
neuronal differentiation, and cell survival (7). In
a retrospective cross-sectional study, the acne
patients were affected twice more to Attention
Deficit Hyperactivity Disorder (ADHD) compared to
other patients (8). Since ADHD is associated with
impaired cognitive functioning, including working
memory, executive function, and attention, a higher
level of ADHD in acne indicates a relationship
between acne and cognitive impairment (23).
Deveci and colleagues (6) studied the cognitive
ability of 66 acne patients and 47 healthy controls.
The acne group showed significantly worse
performance in cognitive tests (learning, verbal
fluency performance, and memory) compared
with the control group (24). Oxidative stress can
cause neurotoxicity through damage to DNA, lipid
peroxidation, and neurotrophin reduction (25).
Thus, perhaps, the two mechanisms for cognitive
impairment in this disease are oxidative stress,
anxiety and depression resulting from acne scars.
In contrast to the aforementioned studies, our
study found no association between acne and
cognitive function.
4.2. Depression, anxiety, and cognitive
ability
The findings of this study showed no connection
between high levels of depression and anxiety
in PCOS patients with cognitive impairment. In
literature, prevalence of depression in women with
PCOS is reported to be from 28 to 64%. High
prevalence of anxiety was observed in PCOS was
reported ranges from 34 to 57%. (26). The literature
review showed cognitive defects (such as memory,
attention, verbal performance, executive function,
psychomotor function, and brain function) in the
cognitive system of depressed and anxious people
(11). Porter and cco-workers (26) found that about
50-75% of depressed patients have cognitive
and memory impairment, called “pseudodementia
depression.” A review of studies revealed only
three research projects with contradictory results.
Kizilbash and co-authors (27) did not show any
association between cognitive impairment and
anxiety, while Beaudreau et al (28) indicated that
depression alone was not related with any type
of cognitive impairment. Therefore, the presence
of both depressive and anxiety disorders will lead
to cognitive impairment (29-30). A number of
researchers have suggested that the association
between anxiety and cognitive function is curved;
they believe that anxiety at a mild level does not
cause memory loss and can also improve cognitive
function. Also, Christensen and Basso stated that
Page 1054 https://doi.org/10.18502/ijrm.v18i12.8026
International Journal of Reproductive BioMedicine Effect of androgen on cognitive performance in PCOS
people having more attacks of depression and
anxiety are at higher risk of cognitive impairment
(31). The subjects in the present study were
young people (mean age = 29.18 yr) who had
less experienced with depression and anxiety
compared to the older individuals.
4.3. Testosterone hormone and
cognition
Our results indicated that there was no
correlation between cognitive function and
androgen levels. However, some studies have
not found these associations (10, 31), but also
others, have reported nearly linear (32) or
nonlinear (33) relationships in this regard. The
high testosterone levels might have a positive
or negative impact on cognitive performance
in women (9, 10). A large number of patients
with PCOS have increased androgen levels
(12). This disorder in androgen production by
the ovaries appears at puberty but is rooted in
childhood or embryonic period (34). Continuous
exposure to testosterone before birth changes
the cortical network related to cognitive ability
(9). Nevertheless, in a review of studies, there are
many contradictory results. Based on the study
of Schattmann and colleagues (9), changes in
the level of free testosterone had no significant
effect on the cognitive function in women with
PCOS. The study of Barry and co-workers
(8) on 69 women with PCOS showed that a
positive correlation exists between the three-
dimensional mental rotation with testosterone
levels. A study on healthy women, a single
sublingual dose of 0.5 mg testosterone caused
improvements in performance on object-location
memory task (35) and visuospatial ability (36).
Thrilers et al (36) showed circulating free
testosterone levels were negatively correlated
with verbal memory task and verbal fluency
performance in women. Some studies (33,
37) have suggested a “curvilinear (inverted U-
shape) relationship between serum testosterone
levels and cognitive ability, whereby higher and
lower levels of testosterone had low cognitive
ability scores, whereas intermediate levels
of testosterone were associated with better
cognitive performance; these findings suggest
that a the level of serum testosterone in mid-
range may be responsible with optimal cognitive
performance”.
In the present study, the cognitive function of
the patients was weaker than that of the healthy
group, but no relationship was found between the
mild cognitive impairment (MCI) and the level of
hormones, which could be due to:
a) Small sample size;
b) Increase in the level of total and free
testosterone, which was higher in the patient group
than in the healthy subjects but was in the normal
range;
c) Duration of exposure to hyperandrogenism:
As observed, the mean age of the participants
was 28-29 yr, so they are less exposed to
hyperandrogenism than the older population. The
duration of the disease may be effective; and
d) In addition to testosterone, other hormones
such as estrogen, LH, FSH, progesterone, prolactin,
and insulin, either alone or in combination, can
be effective in the cognition functions of these
patients. To date, the effect of these hormones
on cognition functions, especially in patients with
PCOS has not been reported.
It should also be taken into account that
the effect of androgen hormones on cognitive
functions is not influenced only by the amount
of testosterone, rather the activity of androgen
receptors and the metabolic activity of androgen
are effective as well, which, in turn, are dependent
to a certain degree on genetic factors.
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4.4. PCOS and cognition
In the present study, the prevalence of MCI
(scores < 26) was 81.1% in the patients and
54% in the control groups. Moreover, there
was a significant difference in the mean levels
of cognitive functioning between groups. This
difference was in the form of a decrease in
cognitive performance (total) in the case group
compared to the control group. To the best of
our knowledge, there is limited research in the
field of cognitive function in patients with PCOS.
The results of Barnard and colleagues (1), and
Ghazeeri et al (37) showed that PCOS women have
poor performance in some domains of cognition.
Although the patient’s group showed poorer
performance on executive ability, visual-spatial
function, and attention, there was no correlation
between this defect and the considered variables.
Cognitive impairment could be due to obesity (38),
insulin resistance (39), and increased estrogen
hormones (40), etc. This research is the first
cohort study in Iran that examined the relationship
between these variables and cognitive impairment
in PCOS women at the same time. According
to the information obtained by performing a
comprehensive review, it is a rare study about
cognitive impairment in patients with PCOS. We
suggest further studieswith larger sample numbers
and different age groups to assess cognitive
function in women as well as to find the causes of
cognitive impairment in these patients.
5. Conclusion
The present study demonstrated that the PCOS
patients had significantly poorer performance on
the tests of verbal fluency, attention, and visual-
spatial function than the healthy control women. No
differences between the two groups were found
on the tests of memory, orientation, and executive
function. Also, there was no correlation between
this defect and levels of free testosterone, TT,
SHBG, acne, hirsutism, depression, and anxiety.
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